Moderate Liver Fibrosis

Drug	Drug Name	Drug Description
DB12914	Resmetirom	A thyroid hormone receptor-beta agonist used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis in adults.

Drug	Drug Name	Target	Type
DB12914	Resmetirom	Cytochrome P450 2C8	enzyme
DB12914	Resmetirom	UDP-glucuronosyltransferase 1-4	enzyme
DB12914	Resmetirom	UDP-glucuronosyltransferase 1-9	enzyme
DB12914	Resmetirom	Solute carrier organic anion transporter family member 1B1	transporter
DB12914	Resmetirom	Solute carrier organic anion transporter family member 1B3	transporter
DB12914	Resmetirom	ATP-binding cassette sub-family G member 2	transporter
DB12914	Resmetirom	Solute carrier family 22 member 8	transporter
DB12914	Resmetirom	Bile salt export pump	transporter
DB12914	Resmetirom	Thyroid hormone receptor beta	target

Drug	Drug Name	Phase	Status	Count